Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M302711200 on April 14, 2003

J. Biol. Chem., Vol. 278, Issue 26, 23817-23822, June 27, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/26/23817    most recent
M302711200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matousek, J.
Right arrow Articles by Libonati, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matousek, J.
Right arrow Articles by Libonati, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Antitumor Activity and Other Biological Actions of Oligomers of Ribonuclease A*

Josef Matousek {ddagger}, Giovanni Gotte §, Pavla Pouckova ¶, Josef Soucek ||, Tomas Slavik {ddagger}, Francesca Vottariello § and Massimo Libonati § **

From the {ddagger}Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech Republic, the §Department of Neurological and Vision Sciences, Section of Biological Chemistry, Medical Faculty, the University of Verona, Strada Le Grazie 8, 37134 Verona, Italy, the Institute of Biophysics, Medical Faculty of Charles University, Prague 12000, Czech Republic, and the ||Institute of Hematology and Blood Transfusion, the University of Prague, Prague 12820, Czech Republic

Dimers, trimers, and tetramers of bovine ribonuclease A, obtained by lyophilization of the enzyme from 40% acetic acid solutions, were purified and isolated by cation exchange chromatography. The two conformers constituting each aggregated species were assayed for their antitumor, aspermatogenic, or embryotoxic activities in comparison with monomeric RNase A and bovine seminal RNase, which is dimeric in nature. The antitumor action was tested in vitro on ML-2 (human myeloid leukemia) and HL-60 (human myeloid cell line) cells and in vivo on the growth of human non-pigmented melanoma (line UB900518) transplanted subcutaneously in nude mice. RNase A oligomers display a definite antitumor activity that increases as a function of the size of the oligomers. On ML-2 and HL-60 cells, dimers and trimers generally show a lower activity than bovine seminal RNase; the activity of tetramers, instead, is similar to or higher than that of the seminal enzyme. The growth of human melanoma in nude mice is inhibited by RNase A oligomers in the order dimers < trimers < tetramers. The action of the two tetramers is very strong, blocking almost completely the growth of melanoma. RNase A dimers, trimers, and tetramers display aspermatogenic effects similar to those of bovine seminal RNase, but, contrarily, they do not show any embryotoxic activity.


Received for publication, March 17, 2003 , and in revised form, April 11, 2003.

* This work was supported by the Grant Agency of the Czech Republic through grant 523/01/0114 and the Italian Ministero dell'Università e della Ricerca Scientifica e Tecnologica (MURST), Progetti di Rilevante Importanza Nazionale (PRIN) 2000, 2001, 2002. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed. Tel.: 39-045-8027166; Fax: 39-045-8027170; E-mail: massimo.libonati{at}univr.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
S. M. Fuchs, T. J. Rutkoski, V. M. Kung, R. T. Groeschl, and R. T. Raines
Increasing the potency of a cytotoxin with an arginine graft
Protein Eng. Des. Sel., October 22, 2007; (2007) gzm051v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Leich, N. Stohr, A. Rietz, R. Ulbrich-Hofmann, and U. Arnold
Endocytotic Internalization as a Crucial Factor for the Cytotoxicity of Ribonucleases
J. Biol. Chem., September 21, 2007; 282(38): 27640 - 27646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Monti and G. D'Alessio
Cytosolic RNase Inhibitor Only Affects RNases with Intrinsic Cytotoxicity
J. Biol. Chem., September 17, 2004; 279(38): 39195 - 39198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Gotte and M. Libonati
Oligomerization of Ribonuclease A: TWO NOVEL THREE-DIMENSIONAL DOMAIN-SWAPPED TETRAMERS
J. Biol. Chem., August 27, 2004; 279(35): 36670 - 36679.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Sica, A. Di Fiore, A. Merlino, and L. Mazzarella
Structure and Stability of the Non-covalent Swapped Dimer of Bovine Seminal Ribonuclease: AN ENZYME TAILORED TO EVADE RIBONUCLEASE PROTEIN INHIBITOR
J. Biol. Chem., August 27, 2004; 279(35): 36753 - 36760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement